Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Short-Term Debt repayments: 2013-2021

  • Amphastar Pharmaceuticals' Short-Term Debt repayments was N/A to $387,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $56.4 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Short-Term Debt repayments of $387,000 as of Q3 2021, which was down 98.45% from $25.0 million recorded in Q2 2014.
  • Over the past 5 years, Amphastar Pharmaceuticals' Short-Term Debt repayments peaked at $387,000 during Q3 2021, and registered a low of $387,000 during Q3 2021.
  • Moreover, its 1-year median value for Short-Term Debt repayments was $387,000 (2021), whereas its average is $387,000.